ADO 4.55% 2.3¢ anteotech ltd

Our partners, page-115

  1. 4,151 Posts.
    lightbulb Created with Sketch. 11910
    ellume is the partner I have high hopes for. (all been posted before) but not in a single post,

    1st we have confirmation in Dereks interview (4.40 min mark), that we are a major factor in their flu test being a success. Ellume has a licence deal for this test with GSK.




    from an interview on ellume webpage and other articles, they are planning a 2020 release.

    "Obviously developing the tech behind this has taken some time, but we’re aiming for a 2020 commercial release and remain on track to achieve that."

    https://finfeed.com/opinion/questio...-diagnostics-company-helping-people-beat-flu/

    then from an article written on the 25th march 2020 from their CEO, DR Sean Parsons

    "We at Ellume are doing our part in responding to COVID-19 (major announcements to come shortly)"

    https://www.ellumehealth.com/2020/03/25/world-tb-day-2020/


    so, ellume are developing a flu test, with test results displayed on your smartphone within 12 minutes of completing the test, in which we are involved, partnering as well, with a pharmaceutical giant GSK. the test has a release date in 2020. ellume has claimed they will have major announcements coming shortly regarding COVID19.  it's still just joining dots but a GSK backed test that we are involved in, would certainly shift the sp, especially if it tests for the antibody.

    time will tell, keep safe!!!
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.001(4.55%)
Mkt cap ! $55.39M
Open High Low Value Volume
2.2¢ 2.3¢ 2.2¢ $4.978K 221.6K

Buyers (Bids)

No. Vol. Price($)
5 1052232 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 857974 5
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
2.2¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
2.3¢ 2.3¢ 2.2¢ 431465
Last updated 15.56pm 14/05/2024 ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.